How many institutions own AGMB stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own AGMB shares is 35, representing 48.45% of the company's common stock.

Who are the major shareholders selling AgomAb Therapeutics N.V. American Depositary Shares stock?

N/A, in the last quarter, reduced its stake in AGMB by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the AGMB shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned AGMB shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying AGMB stock?

As per its latest 13F filing, SANOFI increased its stake in AGMB by 100% in the last quarter. The institutional holder raised its holding to 2.78 million shares having worth more than $29.19M. EQT FUND MANAGEMENT S.A R.L. also added 100% more shares of AGMB to its portfolio, raising its holding to 5.14 million shares of worth $53.94M. CORMORANT ASSET MANAGEMENT, LP also increased its AGMB shares holding by 100% which brought its holding to 2.47 million shares worth $25.86M.

AGMB's major insiders: who are they?

The insider with the most stakes in AGMB is N/A , N/A at the company. Additionally, AGMB stock is highly held by N/A N/A and N/A N/A among others.

Did an insider recently sell AGMB stock?

Company executives, directors, and other insiders own 5.9% percent of AgomAb Therapeutics N.V. American Depositary Shares's stock. Within the last six months, there have been 0 transaction(s) in which AGMB insiders have sold stock, totaling 0 shares. Insiders that have sold shares include .

Which insider recently purchased AGMB stock?

There have been 0 transaction(s) during the past 6-months in which AgomAb Therapeutics N.V. American Depositary Shares insiders have bought stock, totalling 0 shares

How much of AGMB does insiders own?

Around 0 AgomAb Therapeutics N.V. American Depositary Shares shares are held by insiders, which represents about 5.9% of AGMB stock.

Who is the insider with the largest stake?

AGMB N/A, N/A holds the largest portfolio of the company's shares. AGMB shares owned by N/A total nearly -.

Which institution holds the most shares in AGMB?

SANOFI is the largest institutional owner in AGMB which holds 2.78 million shares worth $29.19M or 5.71% of the total AGMB shares outstanding followed by EQT FUND MANAGEMENT S.A R.L. with ownership of 5.14 million shares representing 10.55% of the AGMB ownership. CORMORANT ASSET MANAGEMENT, LP is the third largest stakeholder with 2.47 million shares or 5.06% of the ownership worth more than $25.86M.

Is AgomAb Therapeutics N.V. American Depositary Shares stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the AGMB is concerned, it is a stock which is not optionable.

Is there a short position on AGMB's shares?

Number of AGMB shares short is 1.24M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding AGMB shares are there?

As of today, 49.25M shares of AGMB are outstanding.

Is there many float in AGMB stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, AGMB has 16.41M shares in float.

AGMB short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for AGMB is 10.57.

Stock Ideas

AGMB Stock Ownership Breakdown

NASDAQ : AGMB

AgomAb Therapeutics NV American Depositary Shares

$13.25

-0.18-1.34%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares2.52

Short Percent Of Float3.05

Shares Outstanding49.25M

Shares Float16.41M

Shares Short1.24M

Short Ratio10.57

3.05%

Short % of Float

2.52%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

5.9% Percentage of Shares held by All Insiders

48.45% Percentage of Shares held by All Institutions

51.49% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 48.45% of AGMB shares are held by financial institutions. SANOFI is the top corporate investor, holding 2.78M shares valued at $29.19M. A 5.71% stake in AgomAb Therapeutics N.V. American Depositary Shares is owned by the company. EQT FUND MANAGEMENT S.A R.L. owns 5.14M shares valued at $53.94M, which translates its holding of 10.55% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2026	SANOFI	5.71%	2.78M	29.19M	2.78M	+100.00%
Mar 31, 2026	EQT FUND MANAGEMENT S.A R.L.	10.55%	5.14M	53.94M	5.14M	+100.00%
Mar 31, 2026	CORMORANT ASSET MANAGEMENT, LP	5.06%	2.47M	25.86M	2.47M	+100.00%
Mar 31, 2026	TCG CROSSOVER MANAGEMENT, LLC	4.21%	2.05M	21.54M	2.05M	+100.00%
Mar 31, 2026	LAURION CAPITAL MANAGEMENT LP	0.1%	50K	524.5K	50K	+100.00%
Mar 31, 2026	MORGAN STANLEY	0.01%	3.03K	31.73K	3.03K	+100.00%
Mar 31, 2026	CASDIN CAPITAL, LLC	3.18%	1.55M	16.26M	1.55M	+100.00%
Mar 31, 2026	NANTAHALA CAPITAL MANAGEMENT, LLC	2.46%	1.2M	12.85M	1.2M	+100.00%
Mar 31, 2026	ABRDN PLC	1.45%	707.66K	7.42M	707.66K	+100.00%
Mar 31, 2026	SEVEN GRAND MANAGERS, LLC	0.41%	200K	2.1M	200K	+100.00%
Mar 31, 2026	SBI SECURITIES CO., LTD.	0%	2	21	2	+100.00%
Mar 31, 2026	FEDERATED HERMES, INC.	3.32%	1.62M	16.97M	1.62M	+100.00%
Mar 31, 2026	ANDERA PARTNERS	3.16%	1.54M	16.14M	1.54M	+100.00%
Mar 31, 2026	FMR LLC	2.99%	1.46M	15.3M	1.46M	+100.00%
Mar 31, 2026	PERCEPTIVE ADVISORS LLC	1.23%	600K	6.29M	600K	+100.00%
Mar 31, 2026	SAMSARA BIOCAPITAL, LLC	1.23%	600K	6.29M	600K	+100.00%
Mar 31, 2026	REDMILE GROUP, LLC	0.32%	156.25K	1.64M	156.25K	+100.00%
Mar 31, 2026	PFIZER INC	0.15%	75K	813.75K	75K	+100.00%
Mar 31, 2026	ALYESKA INVESTMENT GROUP, L.P.	0.15%	75K	786.75K	75K	+100.00%
Mar 31, 2026	BELLEVUE GROUP AG	0.1%	50K	524.5K	50K	+100.00%
Mar 31, 2026	SECTORAL ASSET MANAGEMENT INC	0.09%	43.5K	477.3K	43.5K	+100.00%
Mar 31, 2026	GOLDMAN SACHS GROUP INC	0.07%	35.74K	374.9K	35.74K	+100.00%
Mar 31, 2026	CITADEL ADVISORS LLC	0.07%	35K	367.15K	35K	+100.00%
Mar 31, 2026	BURKEHILL GLOBAL MANAGEMENT, LP	0.07%	35K	367.15K	35K	+100.00%
Mar 31, 2026	TWO SIGMA INVESTMENTS, LP	0.03%	14.24K	149.39K	14.24K	+100.00%
Mar 31, 2026	JANE STREET GROUP, LLC	0.03%	12.79K	134.21K	12.79K	+100.00%
Mar 31, 2026	SIREN, L.L.C.	0.84%	411.25K	4.31M	411.25K	+100.00%
Mar 31, 2026	LMR PARTNERS LLP	0.62%	300K	3.15M	300K	+100.00%
Mar 31, 2026	HRT FINANCIAL LP	0.05%	23.73K	248K	23.73K	+100.00%
Mar 31, 2026	D. E. SHAW & CO., INC.	0.03%	15.33K	160.77K	15.33K	+100.00%
Mar 31, 2026	UBS GROUP AG	0.01%	6.44K	67.52K	6.44K	+100.00%
Mar 31, 2026	MILLENNIUM MANAGEMENT LLC	0.2%	95.23K	998.99K	95.23K	+100.00%

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.